S. Mörsdorf

发表

Haemostatical and rheological aspects of dysfibrinogenemia.

F. Jung, C. Mrowietz, U. Seyfert, 1997, Clinical hemorheology and microcirculation.

State-of-the-Art Review : Heparin-Induced Thrombocytopenia: A Critical Risk/Benefit Analysis of Patients in Intensive Care Treated With R-Hirudin

H. Schieffer, B. Krischek, G. Berg, 2000 .

Optimizing therapy with anticoagulants: risk analysis and socio-economic perspectives. Preface.

G. Agnelli, S. Mörsdorf, E. Wenzel, 1999, Seminars in thrombosis and hemostasis.

Dimensions of quality of life and self-monitoring therapy with oral anticoagulants--still research or everyday practice?

J. Schenck, B. Krischek, I. Sibitz, 1999, Seminars in thrombosis and hemostasis.

The use of prothrombin complex concentrates in the treatment of hemorrhages induced by oral anticoagulation.

S. Mörsdorf, G. Pindur, 1999, Thrombosis research.

Analysis and Occurrence of Adverse Events with Oral Anticoagulant Therapy

K. Munter, S. Mörsdorf, G. Pindur, 1999, Seminars in thrombosis and hemostasis.

Training of Patients for Self-Management of Oral Anticoagulant Therapy: Standards, Patient Suitability, and Clinical Aspects

B. Krischek, S. Mörsdorf, E. Wenzel, 1999, Seminars in thrombosis and hemostasis.

[Venous thromboembolism in a young patient. Diagnosis: Retinal vein thromboembolism in mutation of the methylenetetrahydrofolate reductase gene].

A. Palmowski, K. Ruprecht, W. Herrmann, 1999, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

Effects of Aprosulate, a Novel Synthetic Glycosaminoglycan, on Coagulation and Platelet Function Parameters: A Prospective, Randomized Phase I Study

P. Radziwon, H. Breddin, S. Mörsdorf, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

The overdosed patient and bleedings with oral anticoagulation.

B. Krischek, S. Mörsdorf, G. Pindur, 1999, Seminars in thrombosis and hemostasis.

[Quality control of prothrombin complex preparations: in vivo and in vitro findings].

S. Rose, S. Mörsdorf, G. Pindur, 1990, Beitrage zur Infusionstherapie = Contributions to infusion therapy.

The clinical significance of different routes of desmopressin (DDAVP) administration in various bleeding disorders.

G. Leipnitz, S. Mörsdorf, E. Wenzel, 1988, Folia haematologica.

Comparison of different prothrombin complex concentrates--in vitro and in vivo studies.

G. Harbauer, S. Rose, S. Mörsdorf, 1990, Thrombosis research.

In vivo recovery and half-life time of a steam-treated factor IX concentrate in hemophilia B patients

E. Seifried, S. Mörsdorf, G. Pindur, 1988, Blut.

Rational Use of Blood and Blood Components in Hematology and Oncology

L. Trümper, B. Krischek, S. Mörsdorf, 2000, Transfusion Medicine and Hemotherapy.

Quality of Fresh‐Frozen Plasma during Storage

J. Riggert, U. Seyfert, S. Mörsdorf, 1997, Vox sanguinis.

Half-life of single-chain urokinase-type plasminogen activator (scu-PA) and two-chain urokinase-type plasminogen activator (tcu-PA) in patients with acute myocardial infarction.

G. Leipnitz, G. Berg, S. Mörsdorf, 1991, Thrombosis research.

Influence of HIV-Infection on the Karnofsky Score and General Social Functioning in Patients with Hemophilia

S. Mörsdorf, G. Pindur, T. Wenzel, 1998, Pathophysiology of Haemostasis and Thrombosis.

The Prochaska Affair Revisited: Towards a Revaluation of Austria-Hungary’s Balkan Consuls

S. Mörsdorf, 2022, Hungarian Historical Review.

[Clinical hemorheological data on erythrocyte concentrates in additive solution in vivo].

U. Seyfert, S. Mörsdorf, G. Pindur, 2001, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.

Improved Therapeutic Safety of Oral Anticoagulant Therapy in Germany: The Saarland Model

G. Leipnitz, B. Krischek, S. Mörsdorf, 1999, Seminars in thrombosis and hemostasis.